Abstract
Address: 1MRC Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, UK, 2“Aghios Charalambos” Mental Health Unit, Heraklion, Crete, Greece, 3Department of Psychiatry, Harvard Medical School and Psychopharmacology Program, McLean Division of Massachusetts General Hospital, Boston, Massachusetts, USA, 4Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA and 5Lucio Bini Mood Disorder Centre and Department of Psychology, University of Cagliari, Sardinia, Italy * Corresponding author
Highlights
Safety of antidepressants in children and adolescents is being questioned and their efficacy in juvenile depression remains uncertain
Thirty drug-placebo contrasts in RCTs lasting
Findings were similar for rate differences
Summary
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
